Cell populations which co-express CD49C and CD90

Details for Australian Patent Application No. 2009208096 (hide)

Owner Neuronyx, Inc.

Inventors Wagner, Joseph; Herring, W. Joseph; Kopen, Gene C.; Rutkowski, J. Lynn; Ragaglia, Vanessa; Ho, Tony W.; Righter, William F.

Agent Pizzeys

Pub. Number AU-A-2009208096

Parent 2007201194

Filing date 11 August 2009

Wipo publication date 3 September 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61K 35/34 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Muscles

A61K 35/36 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Skin

A61K 35/44 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Eyes

A61K 35/50 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

27 August 2009 Complete Application Filed

3 September 2009 Application Open to Public Inspection

  Published as AU-A-2009208096

17 September 2009 Amendment Made

  The nature of the amendment is: Amend applicant name to Garnet BioTherapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009208097-Filtration system for gas turbines

2009208095-Apparatus and method for automatically adjusting the sail surface exposed to the wind